{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:28:24Z","timestamp":1782232104938,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,27]],"date-time":"2027-01-27T00:00:00Z","timestamp":1801008000000},"content-version":"am","delay-in-days":271,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA027660"],"award-info":[{"award-number":["R01AA027660"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neuropharm.2026.110853","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:38:57Z","timestamp":1769013537000},"page":"110853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ivabradine reduces seizure susceptibility in a genetic model of mixed epilepsies"],"prefix":"10.1016","volume":"288","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6528-1534","authenticated-orcid":false,"given":"Gleice Kelli","family":"Silva-Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7829-7292","authenticated-orcid":false,"given":"Prosper","family":"N'Gouemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110853_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000503831","article-title":"The epidemiology of epilepsy","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neuropharm.2026.110853_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(89)90077-0","article-title":"Anticonvulsant profile of the progesterone metabolite 5 alpha-pregnan-3alpha-o1-20-one","volume":"166","author":"Belelli","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110853_bib3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1152\/physrev.00029.2008","article-title":"Hyperpolarization-activated cation channels: from genes to function","volume":"89","author":"Biel","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2026.110853_bib4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/brain\/awp028","article-title":"Cortical and subcortical networks in human secondarily generalized tonic-clonic seizures","volume":"132","author":"Blumenfeld","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2026.110853_bib5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0014-4886(86)90174-3","article-title":"Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections","volume":"93","author":"Browning","year":"1986","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110853_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.2005.100776","article-title":"Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels","volume":"572","author":"Bucchi","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.110853_bib7","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.biopha.2018.11.096","article-title":"Ivabradine possesses anticonvulsant and neuroprotective action in mice","volume":"109","author":"Cavalcante","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.110853_bib8","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/aps.2010.105","article-title":"Hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels in the regulation of midbrain dopamine systems","volume":"31","author":"Chu","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2026.110853_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-1211(00)00107-8","article-title":"Audiogenic kindling in the Wistar rat: a potential model for recruitment of limbic structures","volume":"39","author":"Dutra Moraes","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2026.110853_bib10","first-page":"311","article-title":"Neuronal networks in the genetically epilepsy-prone rat","volume":"79","author":"Faingold","year":"1999","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110853_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0006-8993(02)02884-6","article-title":"Synaptic plasticity in the pathway from the medial geniculate body to the lateral amygdala is induced by seizure repetition","volume":"946","author":"Feng","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110853_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2017.08.008","article-title":"Structural alterations in fast-spiking GABAergic interneurons in a model of posttraumatic neocortical epileptogenesis","volume":"108","author":"Gu","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2026.110853_bib13","doi-asserted-by":"crossref","first-page":"10979","DOI":"10.1523\/JNEUROSCI.1531-09.2009","article-title":"Loss of dendritic HCN1 subunits enhances cortical excitability and epileptogenesis","volume":"29","author":"Huang","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110853_bib14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0306-4522(96)00503-9","article-title":"The amygdala is critical for seizure propagation from the brainstem to forebrain","volume":"77","author":"Hirsch","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110853_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.seizure.2014.03.014","article-title":"Generalized versus partial reflex seizures: a review","volume":"23","author":"Italiano","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2026.110853_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107790","article-title":"Pharmacoresistance - Epidemiology, mechanisms, and impact on epilepsy treatment","volume":"168","author":"Janmohamed","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110853_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108384","article-title":"Pharmacologically targeting transient receptor potential channels for seizures and epilepsy: emerging preclinical evidence of druggability","volume":"244","author":"Jiang","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2026.110853_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1527-3458.2000.tb00150.x","article-title":"Genetically epilepsy-prone rats (GEPRs) in drug research","volume":"6","author":"Jobe","year":"2000","journal-title":"CNS Drug Rev."},{"issue":"40","key":"10.1016\/j.neuropharm.2026.110853_bib19","doi-asserted-by":"crossref","first-page":"14291","DOI":"10.1523\/JNEUROSCI.1148-11.2011","article-title":"Rapid loss of dendritic HCN channel expression in hippocampal pyramidal neurons following status epilepticus","volume":"31","author":"Jung","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110853_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106484","article-title":"Testing broad-spectrum and isoform-preferring HCN channel blockers for anticonvulsant properties in mice","volume":"168","author":"Kharouf","year":"2020","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2026.110853_bib21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2026.110853_bib22","author":"Lacone"},{"key":"10.1016\/j.neuropharm.2026.110853_bib23","article-title":"Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy","volume":"119","author":"Lazarini-Lopes","year":"2021","journal-title":"Epilepsy Behav. EB"},{"key":"10.1016\/j.neuropharm.2026.110853_bib24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2026.110853_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/emboj\/cdg032","article-title":"Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2","volume":"22","author":"Ludwig","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2026.110853_bib26","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S1734-1140(13)71500-7","article-title":"Ivabradine (a hyperpolarization activated cyclic nucleotide-gated channel blocker) elevates the threshold for maximal electroshock-induced tonic seizures in mice","volume":"65","author":"Luszczki","year":"2013","journal-title":"Pharmacol. Rep. PR"},{"key":"10.1016\/j.neuropharm.2026.110853_bib27","article-title":"Possible anticonvulsant effect of ivabradine in kainite \u2013induced epilepsy in rats: amelioration of oxidative stress","volume":"4","author":"Mansour","year":"2015","journal-title":"World J. Pharmaceut. Res."},{"key":"10.1016\/j.neuropharm.2026.110853_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0920-1211(89)90023-5","article-title":"Audiogenic convulsions in moderate seizure genetically epilepsy-prone rats (GEPR-3s)","volume":"3","author":"Mishra","year":"1989","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2026.110853_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0169-328X(00)00155-8","article-title":"Cloning and localization of the hyperpolarization-activated cyclic nucleotide-gated channel family in rat brain","volume":"81","author":"Monteggia","year":"2004","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuropharm.2026.110853_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0014-4886(92)90197-X","article-title":"Repetition of audiogenic seizures in genetically epilepsy-prone rats induces cortical epileptiform activity and additional seizure behaviors","volume":"115","author":"Naritoku","year":"1992","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuropharm.2026.110853_bib30","series-title":"The National Academies Collection: Reports Funded by National Institutes of Health","article-title":"Guide for the care and use of laboratory animals","year":"2011"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110853_bib31","first-page":"719","article-title":"A behavioral role for dendritic integration: HCN1 channels constrain spatial memory and plasticity at inputs to distal dendrites of CA1 pyramidal neurons","volume":"119","author":"Nolan","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.110853_bib32","series-title":"Jasper's Basic Mechanisms of the Epilepsies","article-title":"Hyperpolarization-activated cyclic nucleotide-gated (HCN) ion channelopathy in epilepsy","author":"Poolos","year":"2012"},{"key":"10.1016\/j.neuropharm.2026.110853_bib33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nrd3576","article-title":"Exploring HCN channels as novel drug targets","volume":"10","author":"Postea","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2026.110853_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation: II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.110853_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2005.09.047","article-title":"Pontine reticular formation neurons are implicated in the neuronal network for generalized clonic seizures, which is intensified by audiogenic kindling","volume":"1064","author":"Raisinghani","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110853_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fncel.2013.00115","article-title":"Role of hormones and neurosteroids in epileptogenesis","volume":"7","author":"Reddy","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110853_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev-pharmtox-010919-023356","article-title":"Hyperpolarization-activated cyclic nucleotide-gated channels as drug targets for neurological disorders","volume":"60","author":"Santoro","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2026.110853_bib38","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/j.1528-1167.2010.02554.x","article-title":"Increased seizure severity and seizure-related death in mice lacking HCN1 channels","volume":"51","author":"Santoro","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2026.110853_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eplepsyres.2017.04.011","article-title":"Ivabradine attenuates the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice","volume":"133","author":"Sawicka","year":"2017","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2026.110853_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/exnr.1999.7036","article-title":"Spatial and temporal relationships between C-Fos expression and kindling of audiogenic seizures in wistar rats","volume":"157","author":"Simler","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110853_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105633","article-title":"Neuronal circuits sustaining neocortical-injury-induced status epilepticus","volume":"165","author":"Singh","year":"2022","journal-title":"Neurobiol. Dis."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T09:39:02Z","timestamp":1770629942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"alternative-id":["S0028390826000262"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110853","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivabradine reduces seizure susceptibility in a genetic model of mixed epilepsies","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110853"}}